000 01293 a2200421 4500
005 20250516170604.0
264 0 _c20140801
008 201408s 0 0 eng d
022 _a1875-9114
024 7 _a10.1002/phar.1342
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHampp, Christian
245 0 0 _aUse of prescription antiobesity drugs in the United States.
_h[electronic resource]
260 _bPharmacotherapy
_cDec 2013
300 _a1299-307 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnti-Obesity Agents
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDatabases, Factual
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aObesity
_xdrug therapy
650 0 4 _aPractice Patterns, Physicians'
_xstatistics & numerical data
650 0 4 _aTime Factors
650 0 4 _aUnited States
650 0 4 _aWeight Loss
650 0 4 _aYoung Adult
700 1 _aKang, Elizabeth M
700 1 _aBorders-Hemphill, Vicky
773 0 _tPharmacotherapy
_gvol. 33
_gno. 12
_gp. 1299-307
856 4 0 _uhttps://doi.org/10.1002/phar.1342
_zAvailable from publisher's website
999 _c23072354
_d23072354